These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Platelet antigens, antibodies and related clinical conditions]. Muñiz Díaz E Sangre (Barc); 1991 Oct; 36(5):395-415. PubMed ID: 1840085 [No Abstract] [Full Text] [Related]
3. Is immune thrombocytopenic purpura (ITP) due to natural antibodies specific to platelets? Souberbielle BE Eur J Haematol; 1996 Mar; 56(3):178-80. PubMed ID: 8598239 [No Abstract] [Full Text] [Related]
4. Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients. Grodzicky T; Bussel JB; Elkon KB Clin Exp Immunol; 2002 Feb; 127(2):289-92. PubMed ID: 11876752 [TBL] [Abstract][Full Text] [Related]
9. A case of 'auto-immune thrombocytopenic purpura' serologically similar to post-transfusion purpura. Taaning E; Killmann SA Vox Sang; 1992; 62(2):108-12. PubMed ID: 1519365 [TBL] [Abstract][Full Text] [Related]
10. Characterization of novel platelet and endothelial cell target antigens in a family with genetic susceptibility to autoimmunity. Hashemi S; Drouin J; Trudel E; Aye MT; Couture R; Page D; Ganz PR Am J Hematol; 1991 Dec; 38(4):293-303. PubMed ID: 1746538 [TBL] [Abstract][Full Text] [Related]
11. Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia. Vollenberg R; Jouni R; Norris PAA; Burg-Roderfeld M; Cooper N; Rummel MJ; Bein G; Marini I; Bayat B; Burack R; Lazarus AH; Bakchoul T; Sachs UJ Haematologica; 2019 Jun; 104(6):1237-1243. PubMed ID: 30923095 [TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Brighton TA; Evans S; Castaldi PA; Chesterman CN; Chong BH Blood; 1996 Jul; 88(1):194-201. PubMed ID: 8704174 [TBL] [Abstract][Full Text] [Related]
13. Serological, biochemical, and molecular aspects of platelet autoantigens. Kiefel V; Santoso S; Mueller-Eckhardt C Semin Hematol; 1992 Jan; 29(1):26-33. PubMed ID: 1570540 [No Abstract] [Full Text] [Related]
14. Antiplatelet antibodies in childhood idiopathic thrombocytopenic purpura. Ozsoylu S Am J Hematol; 1996 Apr; 51(4):328. PubMed ID: 8602636 [No Abstract] [Full Text] [Related]
15. Genetic analysis of HLA- and HPA-typing in idiopathic (autoimmune) thrombocytopenic purpura patients treated with cepharanthin. Nomura S; Matsuzaki T; Yamaoka M; Ozaki Y; Nagahama M; Yoshimura C; Kagawa H; Nakayama S; Fukuhara S Autoimmunity; 1999; 30(2):99-105. PubMed ID: 10435723 [TBL] [Abstract][Full Text] [Related]
16. Antiplatelet glycoprotein autoantibodies in patients with autoimmune diseases with and without thrombocytopenia. Cordiano I; Salvan F; Randi ML; Ruffatti MA; Steffan A; Girolami A; Fabris F J Clin Immunol; 1996 Nov; 16(6):340-7. PubMed ID: 8946279 [TBL] [Abstract][Full Text] [Related]
17. Anti-GMP140 (CD62) autoantibody in a patient with autoimmune thrombocytopenic purpura. Bierling P; Bettaieb A; Fromont P; Favrin M; Duedari N Br J Haematol; 1994 Jul; 87(3):631-3. PubMed ID: 7527649 [TBL] [Abstract][Full Text] [Related]